For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

Drug susceptibility testing (DST) in Mycobacterium tuberculosis remains the cornerstone of effective tuberculosis control, guiding the choice of therapy and informing public health strategies to ...

The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...

In response to the escalating challenges posed by the high drug resistance of rapidly growing mycobacteria (RGM), a collaborative team from the Qingdao Institute of Bioenergy and Bioprocess Technology ...

Strengthening health delivery systems is critical to achieving the global targets towards ending the tuberculosis (TB) epidemic; such strengthening includes introducing accurate diagnostic methods for ...

Tuberculosis remains one of the deadliest infectious diseases on the planet, and the rise of drug-resistant strains has made ...

Antimicrobial resistance (AMR) directly causes an estimated 1.3 million deaths around the globe annually, a figure that the World Health Organization has predicted will rise. A leading cause of AMR is ...

A new method for identifying the pathogens involved in sepsis cases, which could help to select optimal therapeutics, is reported in Nature. The test has the potential to reduce the turnaround times ...

Viable bacteria in the blood, i.e., bacteremia, can lead to bloodstream infection (BSI) and sepsis, a syndromic, often fatal, inflammatory response. Rapid and accurate antimicrobial prescriptions are ...

PhAST Corp., an in vitro diagnostics company building a single-cell computer vision platform for rapid phenotypic testing across clinical microbiology, today announced that it has received 510(k) ...